- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokine-Based Therapy in Psoriasis
Authors
Keywords
Psoriasis, Biological treatment, IL-12, IL-23, IL-17, IL-22
Journal
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume 44, Issue 2, Pages 173-182
Publisher
Springer Nature
Online
2012-03-17
DOI
10.1007/s12016-012-8306-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the Interleukin-12/23 Cytokine Family in the Treatment of Psoriatic Disease
- (2015) Neil H. Shear et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives
- (2011) Newman Yeilding et al. Annals of the New York Academy of Sciences
- Research in practice: IL-22 and IL-20: significance for epithelial homeostasis and psoriasis pathogenesis
- (2011) Robert Sabat et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Innate and Adaptive Interleukin-17–producing Lymphocytes in Chronic Inflammatory Lung Disorders
- (2010) Bart M. Vanaudenaerde et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Increased IL-23 Expression in Palmoplantar Psoriasis and Hyperkeratotic Hand Dermatitis
- (2010) Joseph V. Lillis et al. ARCHIVES OF DERMATOLOGY
- A novel role for IL-22R1 as a driver of inflammation
- (2010) R. Savan et al. BLOOD
- Suppression of TNF- and IL-1 Signaling Identifies a Mechanism of Homeostatic Regulation of Macrophages by IL-27
- (2010) G. D. Kalliolias et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: A Critical Functional Role for IL-23 in Psoriasis
- (2010) G. Tonel et al. JOURNAL OF IMMUNOLOGY
- IL-23-Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A
- (2010) H. L. Rizzo et al. JOURNAL OF IMMUNOLOGY
- IL-23 and IL-17A, but Not IL-12 and IL-22, Are Required for Optimal Skin Host Defense against Candida albicans
- (2010) S. Kagami et al. JOURNAL OF IMMUNOLOGY
- Generation of pathogenic TH17 cells in the absence of TGF-β signalling
- (2010) Kamran Ghoreschi et al. NATURE
- Psoriasis Bench to Bedside
- (2009) Rajan P. Nair et al. ARCHIVES OF DERMATOLOGY
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
- (2009) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- Long-term safety of biologics in dermatology
- (2009) Xinaida T. Lima et al. Dermatologic Therapy
- Briakinumab
- (2009) Xinaida Taligare Lima et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells
- (2009) Kristine E. Nograles et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis
- (2009) Vinod Chandran et al. JOURNAL OF AUTOIMMUNITY
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not
- (2009) Kerstin Wolk et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Interleukin-23 and Th17 Cells in the Control of Gut Inflammation
- (2009) Ivan Monteleone et al. MEDIATORS OF INFLAMMATION
- Properties and origin of human Th17 cells
- (2009) Sergio Romagnani et al. MOLECULAR IMMUNOLOGY
- Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
- (2009) Thomas Duhen et al. NATURE IMMUNOLOGY
- Interleukin-17 and Type 17 Helper T Cells
- (2009) Pierre Miossec et al. NEW ENGLAND JOURNAL OF MEDICINE
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autoimmune diseases induced by TNF-targeted therapies
- (2008) Manuel Ramos-Casals et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Functional Characterization of IL-17F as a Selective Neutrophil Attractant in Psoriasis
- (2008) Hideaki Watanabe et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses
- (2008) Elisabetta Volpe et al. NATURE IMMUNOLOGY
- Structure of IL-22 Bound to Its High-Affinity IL-22R1 Chain
- (2008) Brandi C. Jones et al. STRUCTURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started